Screening for retinopathy of prematurity: Do former guidelines still apply?

Journal of Pediatric Ophthalmology and Strabismus

Volumn 33, Issue 1, 1996, Pages 35-38

  Schalij Delfos, Nicoline E ^a   Zijlmans, Bart L M ^b   Wittebol Post, Darel ^a   Tan, Karel E W P ^c   Cats, Bernard P ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PROTOCOL; DISEASE ASSOCIATION; EARLY DIAGNOSIS; FEMALE; HIGH RISK POPULATION; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; PREMATURITY; RETINOPATHY; RISK ASSESSMENT; VERY LOW BIRTH WEIGHT;

BIRTH WEIGHT; FEMALE; GESTATIONAL AGE; GUIDELINES; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MASS SCREENING; RETINOPATHY OF PREMATURITY; RETROSPECTIVE STUDIES;

EID: 0030045489     PISSN: 01913913     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Ben Sira I, Nissenkorn I, Kremer I. Retinopathy of prematurity. Surv Ophthalmol. 1988;33:1-17.
2. Kinsey VE. Retrolental fibroplasia. Cooperative study of retrolental fibroplasia and the use of oxygen Arch Ophthalmol. 1956;56:481-543.
3. Avery ME, Oppenheimer EH. Recent increase in mortality from hyaline membrane disease. J Pediatr. 1960;57;553-559.
4. McDonald A. Cerebral palsy in children of very low birth weight. Arch Dis Child. 1963;38:579-588.
5. Ben Sira I, Nissenkorn I, Weinberger D, et al. Long-term results of cryotherapy for active stages of retinopathy of prematurity. Ophthalmology. 1986;93:1423-1423.
6. Nagata M, Kobayashi Y, Fukuda H, Sue Kane K. Photocoagulation for the treatment of the retinopathy of prematurity. J Clin Ophthalmol Jpn 1968;22;419-427.
7. Payne JN, Patz A. Treatment of acute proliferative retrolental fibroplasia. Trans Am Acad Ophthalmol Otolaryngol. 1972;76:1234-1241.
8. Committee for the classification of retinopathy of prematurity An international classification of retinopathy of prematurity. Arch Ophthalmol. 1984;102:1130-1104.
9. Committee for the classification of the late stages of retinopathy of prematurity. An international classification of retinopathy of prematurity, II: the classification of retinal detachment. Arch Ophthalmol. 1987;105:906-912.
10. Yu VYH, Hookham DM, Nave JRM. Retrolental fibroplasia-controlled study of 4 years' experience in a neonatal intensive care unit. Arch Dis Child. 1982;57:247-252.
11. Hittner HM, Godio LE, Speer ME, et al. Retrolental fibroplasia: farther clinical evidence and ultrastructural support for efficacy of vitamin E in the preterm infant. Paediatrics. 1983;71:423-432.
12. Finer NN, Schindler RF, Peters KL, Grant GD. Vitamin E and retrolental fibroplasia, improved visual outcome with early vitamin E. Ophthalmology 1983;90:428-434.
13. Palmer EA. Optimal timing of examination for acute retrolental fibroplasia. Ophthalmology. 1981;88:662-668.
14. Campbell PB, Bull MJ, Ellis FD, Bryson CQ, Lemons JA, Schreiner RL. Incidence of retinopathy of prematurity in a tertiary newborn intensive care unit. Arch Ophthalmol. 1983;101:1686-1688.
15. Kalina RE, Karr DJ. Retrolental fibroplasia; experience over two decades in one institution. Ophthalmology. 1982;89:91-95.
16. Vohr BR, Garcia Coll CT Increased morbidity in low birth weight survivors with severe retrolental fibroplasia. J Pediatr. 1985;106:287-291.
17. Schaffer DB, Quinn GE, Johnson L. Sequela of arrested mild retinopathy of prematurity. Arch Ophthalmol. 1984;102:373-376.
18. Biglan AW, Brown DR, Reynolds JD, Milley JR. Risk factors associated with retrolental fibroplasia. Ophthalmology. 1984;39:307-317.
19. Cats BP, Tan KEWP. Optimal strategy for ROP screening. In: Ben Ezra D, Ryan SJ, Glaser BM, Murphy RF, eds. Ocular Circulation and Neovascularisation. Amsterdam: Martinus Nijhoff/Dr W Junk Publishers; 1987;135-139.
20. Cats BP, Tan KEWP. Retinopathy of prematurity: review of a four-year period. Br J Ophthalmol. 1985;69:500-503.
21. Schaffer DB, Palmer EA, Plotsky DF, et al. Cryotherapy for Retmopathy of Prematurity Cooperative Group Prognostic factors in the natural course of retinopathy of prematurity. Ophthalmology. 1993;100:230-236.
22. Tan KEWP, Cats BP. Timely incidence of retinopathy of prematurity (ROP) and its consequences for the screening strategy. Am J Perinatol. 1989;6:337-340
23. Cooke RWI. Annual audit of three-year outcome in very low birth weight infants. Arch Dis Child 1993;69:295-298.
24. Jakobi P, Weissman A, Paldi E. The extremely low birth weight infant: the twenty-first century dilemma. Am J Perinatol. 1993;10:155-159.
25. Fielder AR, Shaw DE, Robinson J, Yin KNG. Natural history of retinopathy of prematurity : a prospective study. Eye. 1992;6:233-242.
26. Cats BP, Tan KEWP. Unexpected occurrence of retinopathy of prematurity: is there a need for custom-made screening procedures? Acta Ped Scand. 1987;76:751-753.
27. Flynn JT. Bancalari E, Bachynski BN, et al. Retinopathy of prematurity Diagnosis, severity and natural history. Ophthalmology. 1987;94:620-629.
28. Schulenburg WE, Prendiville A, Ohri R. Natural history of retinopathy of prematurity. Br J Ophthalmol. 1987;71:837-843.
29. Palmer EA, Flynn JT, Hardy RJ, et al. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Incidence and early course of retinopathy of prematurity. Ophthalmology. 1991;98:1628-1640.
30. Fielder AR, Ng YK, Levene MI. Retinopathy of prematurity: age at onset. Arch Dis Child. 1986;61:774-778.
31. Quinn GE, Johnson L, Abbasi S. Onset of ROP as related to postnatal and postconceptual age. Br J Ophthalmol. 1992;76:284-288.